Suvretta Capital Management »

Sensei Biotherapeutics shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 35k 31.52

More positions owned by Suvretta Capital Management

Arcutis Biotherapeutics (ARQT)
Veradermics Common Stock
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Palvella Therapeutics Inc Ne (PVLA)
Apellis Pharmaceuticals (APLS)
Legend Biotech Corp Sponsored Ads (LEGN)
Benitec Biopharma Com New (BNTC)
Capricor Therapeutics Com New (CAPR)
Immatics SHS (IMTX)
Arcus Biosciences Incorporated (RCUS)
Eyepoint Com New (EYPT)
Arrivent Biopharma (AVBP)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)

View all positions for Suvretta Capital Management

Top funds holding Sensei Biotherapeutics

Vivo Capital
Cormorant Asset Management
Millennium Management
Franklin Resources
Stempoint Capital
Trails Edge Capital Partners
Goldman Sachs Group
Hrt Financial
Suvretta Capital Management
Bank of America Corporation
Logos Global Management
Boothbay Fund Management
Brevan Howard Capital Management
Fred Alger Management
Balyasny Asset Management

View all funds holding Sensei Biotherapeutics